Mb Bch

Sep 13, 2023 | medscape.com | Robert Byrne |Mb Bch |Rasha Al-Lamee

Recorded August 28, 2023. This transcript has been edited for clarity. Robert A. Byrne, MB BCh, PhD: Hello and welcome. My name is Robert Byrne. I'm a cardiologist working in Dublin, Ireland. I'm very pleased to be here at ESC 2023 in Amsterdam. I'm delighted to be joined by a friend and colleague, Rasha Al-Lamee. Rasha Al-Lamee, MBBS, MA, PhD: Hi, Rob. Byrne: Rasha is from London in the UK.

Aug 16, 2023 | thelancet.com | Mb Bch |Christopher Byrne |Byrne CD |Herbert Tilg

Summary Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide. Although NAFLD is tightly linked to obesity and type 2 diabetes, this liver disease also affects individuals who do not have obesity. NAFLD increases the risk of developing cardiovascular disease, chronic kidney disease, and certain extrahepatic cancers. There is currently no licensed pharmacotherapy for NAFLD, despite numerous clinical trials in the past two decades.

Aug 16, 2023 | shorturl.at | Mb Bch |Christopher Byrne |Byrne CD |Herbert Tilg

Summary Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide. Although NAFLD is tightly linked to obesity and type 2 diabetes, this liver disease also affects individuals who do not have obesity. NAFLD increases the risk of developing cardiovascular disease, chronic kidney disease, and certain extrahepatic cancers. There is currently no licensed pharmacotherapy for NAFLD, despite numerous clinical trials in the past two decades.

Feb 1, 2023 | jamanetwork.com | Mb Bch |Patrick D. McGorry

In the Original Investigation titled “Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence,”1 which published in the January 2021 issue, there were errors in the Results and eTable 9 in the Supplement.